George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

The Financial Prosecutor’s Office has decided to lift the protection status of witnesses in a bribery case involving Swiss pharmaceutical giant Novartis, doctors and public officials following ...

In its upcoming report, Novartis (NVS) is predicted by Wall Street analysts to post quarterly earnings of $1.94 per share, reflecting an increase of 11.5% compared to the same period last year.

Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...

In a report released on October 22, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...

BP’s program includes a novel PSMA-binding molecule that may be a potential next-generation radioligand therapy (RLT) for prostate cancer and is currently being studied in two investigator-initiated ...

Novartis Pharmaceuticals Corp. was sued Thursday in federal court by four female pharmaceutical sales managers who say the company discriminated against them based on their age and gender when they ...

As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...

Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare companies, Novartis (NYSE: NVS), has decided that it will sit on the ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. | Novartis is paying ...